View ISPE Boston Area Chapter's top competitors like American Association of Pharmaceutical Scientists (AAPS) | @aapscomms, BioProcess International, and Bluegrass Pediatrics & Internal Medicine PLLC.
Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
Our operations are strategically located in:
Lincoln, Nebraska (Corporate Headquarters)
Philadelphia, Pennsylvania
Phoenix, Arizona
Belfast, Northern Ireland,UK
Zurich, Switzerland
Vienna, Austria
Richmond, Virginia
Montreal, Quebec, Canada
For more information, visit: www.celerion.com
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest non-profit association serving its members through leading scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The 25,000+ members of ISPE are developing and manufacturing safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 120+ countries worldwide. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,500 members worldwide.